Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model (Q86800012)
Jump to navigation
Jump to search
scientific article published on 01 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model |
scientific article published on 01 February 2014 |
Statements
Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model (English)
Beibei Luo
Bo Li
Wenke Wang
Xiangjuan Liu
Xiaoman Liu
Yanfei Xia
Cheng Zhang
Yun Zhang
Mingxiang Zhang